To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05977322
Title A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP | CHE

Facility Status City State Zip Country Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Geneve 14 CH 1211 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field